Literature DB >> 28796747

Morphologic and Immunohistochemical Study of Clear Cell Carcinoma of the Uterine Endometrium and Cervix in Comparison to Ovarian Clear Cell Carcinoma.

Baohui Ju1, Jianmei Wang, Bo Yang, Lin Sun, Yuhong Guo, Quan Hao, Jianghua Wu.   

Abstract

Endometrial clear cell carcinoma (ECCC) and clear cell adenocarcinoma of the cervix (CCAC) are uncommon gynecologic cancers that have morphologic and phenotypic features similar to ovarian clear cell carcinoma (OCCC), but the 3 entities may not be completely identical. This study identified the morphologic and phenotypic characteristics and the differences between ECCC and CCAC in comparison to OCCC. The morphologic features of 16 ECCCs, 7 CCACs, and 22 OCCCs are described. The immunoprofiles of hepatocyte nuclear factor (HNF) 1β, napsin A, estrogen, progesterone, p53, and Ki-67 were assessed. The results confirm that clear cell carcinomas of the gynecologic tract have a similar spectrum of histopathologic features with the exception that ECCCs have focal solid components more often than CCACs and OCCCs and ECCCs have a slightly higher average mitotic index. Similar to OCCCs, both ECCCs and CCACs were positive for HNF1β and napsin A, and rarely expressed estrogen and progesterone. HNF1β was a sensitive marker for clear cell carcinoma at all 3 sites. Napsin A was less sensitive in ECCCs than in OCCCs (56.3% vs. 90.9%, P=0.021). The average Ki-67 index was higher in ECCCs than in OCCCs (52.6% vs. 39.1%) in hotspot scoring, and more ECCC cases had a higher expression (56.3% vs. 22.7%). Diffuse p53 expression, which is associated with TP53 mutation, was observed slightly more often in ECCCs than in OCCCs (25% vs. 9.1%). Our findings revealed morphologic and immunophenotypic similarities and differences among different gynecologic clear cell carcinomas, which may help in improving diagnosis and knowledge of CCC in the female genital tract.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28796747     DOI: 10.1097/PGP.0000000000000430

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  6 in total

1.  Centromere protein U facilitates metastasis of ovarian cancer cells by targeting high mobility group box 2 expression.

Authors:  Hongjuan Li; Hui Zhang; Yali Wang
Journal:  Am J Cancer Res       Date:  2018-05-01       Impact factor: 6.166

2.  Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.

Authors:  Simona Stolnicu; Iulia Barsan; Lien Hoang; Prusha Patel; Luis Chiriboga; Cristina Terinte; Anna Pesci; Sarit Aviel-Ronen; Takako Kiyokawa; Isabel Alvarado-Cabrero; Malcolm C Pike; Esther Oliva; Kay J Park; Robert A Soslow
Journal:  Am J Surg Pathol       Date:  2018-08       Impact factor: 6.394

3.  Napsin A Expression in Subtypes of Thyroid Tumors: Comparison with Lung Adenocarcinomas.

Authors:  Jianghua Wu; Yanhui Zhang; Tingting Ding; Runfen Cheng; Wenchen Gong; Yuhong Guo; Ye Luo; Yi Pan; Qiongli Zhai; Wei Sun; Dongmei Lin; Baocun Sun
Journal:  Endocr Pathol       Date:  2020-03       Impact factor: 3.943

4.  Napsin-A and AMACR are Superior to HNF-1β in Distinguishing Between Mesonephric Carcinomas and Clear Cell Carcinomas of the Gynecologic Tract.

Authors:  Jennifer Pors; Sheila Segura; Angela Cheng; Jennifer X Ji; Basile Tessier-Cloutier; Dawn Cochrane; Daniel J Fix; Kay Park; Blake Gilks; Lynn Hoang
Journal:  Appl Immunohistochem Mol Morphol       Date:  2020-09

5.  Cervical clear cell adenocarcinoma with an exceptionally low proliferation index: Report of a case.

Authors:  Mary G Dandulakis; Aidas J Mattis; Andrea R Hagemann; Ian S Hagemann
Journal:  Gynecol Oncol Rep       Date:  2018-01-02

6.  Clear Cell Carcinoma of the Endometrium: Evaluation of Prognostic Parameters in 27 Cases.

Authors:  Zhiyang Zhang; Penglian Gao; Zhengqi Bao; Linggong Zeng; Junyi Yao; Damin Chai; Tian Li
Journal:  Front Oncol       Date:  2021-12-02       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.